What are the normal serum TSH reference ranges for each age group?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

TSH Reference Ranges by Age

For adults under 60 years, use TSH reference range of 0.4-4.5 mIU/L, but for elderly patients aged 60 and above, apply an age-adjusted upper limit calculated as the patient's age decade divided by 10 (e.g., ≤7 mIU/L for 70-year-olds, ≤8 mIU/L for 80-year-olds). 1

Standard Adult Reference Range (Ages 12-59)

The lower limit of TSH remains 0.4-0.45 mIU/L across all adult ages and is relatively unaffected by aging 2, 1. The upper limit for younger and middle-aged adults is 4.0-4.5 mIU/L 2, 1.

The landmark NHANES III study established the reference range of 0.45-4.12 mIU/L in disease-free adults aged 12+ years, with a geometric mean of 1.4 mIU/L 2. This was derived from over 13,000 individuals rigorously screened to exclude thyroid disease, antibodies, and interfering medications.

Age-Adjusted Ranges for Elderly (≥60 Years)

The critical clinical point is that TSH physiologically increases with age, particularly the upper limit of normal. The TSH distribution shows a rightward skew in elderly populations, meaning higher values may still be physiologic 1.

Practical Age-Specific Upper Limits:

  • Ages 60-69: Upper limit ≤6-7 mIU/L 1, 3
  • Ages 70-79: Upper limit ≤7-8 mIU/L 1, 3
  • Ages ≥80: Upper limit ≤8 mIU/L 1, 3

The French Endocrine Society provides a simple pragmatic formula: use the patient's age decade divided by 10 as the upper limit (e.g., for a 75-year-old, use ≤7.5 mIU/L) 1. This Grade 2+ recommendation acknowledges that universal reference values are not appropriate for elderly patients.

Pediatric and Adolescent Considerations

Recent research shows adolescents (10-18 years) may have higher TSH levels, particularly in iodine-excess populations, with reference ranges up to 7.35 mIU/L 4. Neonates have the widest range (0.50-22.41 mIU/L), which progressively narrows through childhood 5.

Critical Clinical Caveats

Why Age Matters:

Using a fixed upper limit of 4.0-4.5 mIU/L in elderly patients leads to significant overdiagnosis of subclinical hypothyroidism. Studies show 6.5% of patients aged 60-79 and 12.5% of those ≥80 would be misdiagnosed if age-specific ranges aren't applied 3.

Sex Differences Are Minimal:

While women tend to have slightly higher TSH levels than men, the differences are not clinically significant enough to warrant separate reference ranges in routine practice 2, 6. The exception is pregnancy, which requires different ranges entirely.

Important Confounders to Exclude:

  • Acute illness: TSH can decrease during acute medical conditions; recheck after resolution 1
  • Medications: Dopamine, glucocorticoids, amiodarone, lithium all affect TSH 1
  • Thyroid antibodies: Anti-TPO positivity shifts the population distribution 2
  • Assay interference: Heterophilic antibodies and macro-TSH can cause false elevations 1

When to Repeat Testing:

A TSH change must exceed 40% between measurements to be clinically significant due to biological and analytical variability 1. Don't overreact to small fluctuations within the reference range.

Algorithm for TSH Interpretation

  1. Measure TSH alone as first-line test (not FT4 or antibodies initially) 1
  2. Apply age-appropriate reference range:
    • Under 60: 0.4-4.5 mIU/L
    • 60-69: 0.4-6 to 7 mIU/L
    • 70-79: 0.4-7 to 8 mIU/L
    • ≥80: 0.4-8 mIU/L
  3. If TSH is outside range, then measure FT4 to distinguish overt from subclinical dysfunction
  4. If borderline elevated in elderly (TSH 4.5-7 mIU/L with normal FT4), consider this potentially normal for age rather than automatically diagnosing subclinical hypothyroidism
  5. Confirm abnormal results with repeat testing after excluding acute illness and interfering medications

The evidence strongly supports that mild TSH elevations (4.5-7 mIU/L) in elderly patients with normal FT4 are not associated with adverse geriatric outcomes like sarcopenia or cerebral microbleeds, whereas TSH ≥7 mIU/L does show such associations 7. This reinforces using higher age-specific thresholds before initiating treatment.

Related Questions

What are the normal serum thyroid-stimulating hormone (TSH) levels for adults, including variations during pregnancy and in older adults?
Is a TSH of 5.6 mIU/L considered normal in a 65‑year‑old patient?
Is a thyroid-stimulating hormone (TSH) level of 3.4 mIU/L normal in a 75‑year‑old woman?
Is a thyroid‑stimulating hormone (TSH) level of 6.89 µIU/mL acceptable in a 64‑year‑old male?
How should a 53-year-old adult with an elevated thyroid‑stimulating hormone (TSH) of 8.81 mIU/L and a normal free thyroxine (free T4) of 1.3 ng/dL be evaluated and managed?
What are the clinical, laboratory, and imaging features of Kawasaki disease myocarditis in children?
In a patient with a serum potassium of 5.2 mmol/L, should the test be repeated in primary care or is this mild hyperkalaemia that does not require further follow‑up?
Is polyethylene glycol (PEG) safe to use in a patient with a recent jejunal intramural hematoma who is on a gradual solid diet after 2 days of bowel rest, with flatus but no stool?
Is visualization of the thymus on cervical ultrasound in a healthy adolescent a physiologic finding?
In a patient with a recent jejunal intramural hematoma who was previously taking bisacodyl daily for bowel movements, can polyethylene glycol (PEG) be started now?
What starting dose of levothyroxine (synthetic T4) should be used in a patient with a thyroid‑stimulating hormone of 5.37 mIU/L and a free thyroxine of 0.65 ng/dL who is transitioning from liothyronine (T3) therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.